D J Vaughn|S B Malkowicz - JoVE Visualize

Showing results (81-90 of 123) with videos related to

Pageof 13

Sort By:

The American Journal of Gastroenterology|April 1, 1995

Chronic lymphocytic leukemia: an unusual cause of upper gastrointestinal hemorrhageD O Faigel, D J Vaughn, E E Furth, et al.

Medical Oncology (Northwood, London, England)|February 10, 1999

Combined radiation and chemotherapy in posttransplant lymphoproliferative disorderD E Tsai, E A Stadtmauer, D J Canaday, et al.

Urology|May 9, 2003

Clinical characteristics of prostate cancer in African Americans, American whites, and Senegalese menS M Gueye, C M Zeigler-Johnson, T Friebel, et al.

International Journal of Radiation Oncology, Biology, Physics|December 29, 1999

Optimizing patient selection for dose escalation techniques using the prostate-specific antigen level, biopsy gleason score, and clinical T-stageA V D'Amico, R Whittington, S B Malkowicz, et al.

AJNR. American Journal of Neuroradiology|July 1, 1993

High-dose cytarabine neurotoxicity: MR findings during the acute phaseD J Vaughn, J G Jarvik, D Hackney, et al.

Cancer|January 28, 1998

Calculated prostate carcinoma volume: The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliterA V D'Amico, R Whittington, I Kaplan, et al.

The Journal of Urology|November 16, 2007

Toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: interim analysis of a multicenter phase 3 clinical studyM R Smith, S B Malkowicz, F Chu, et al.

International Journal of Radiation Oncology, Biology, Physics|October 6, 1997

Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTVA V D'Amico, R Whittington, I Kaplan, et al.

The Journal of Urology|November 20, 1997

Collagen injection therapy for post-radical retropubic prostatectomy incontinence: role of Valsalva leak point pressureR F Sánchez-Ortiz, G A Broderick, D C Chaikin, et al.

Urology|December 23, 2008

Does race affect postoperative outcomes in patients with low-risk prostate cancer who undergo radical prostatectomy?M J Resnick, D J Canter, T J Guzzo, et al.

Pageof 13

Showing results (81-90 of 123) with videos related to

Sort By:

Pageof 13

The American Journal of Gastroenterology|April 1, 1995

Chronic lymphocytic leukemia: an unusual cause of upper gastrointestinal hemorrhageD O Faigel, D J Vaughn, E E Furth, et al.

Medical Oncology (Northwood, London, England)|February 10, 1999

Combined radiation and chemotherapy in posttransplant lymphoproliferative disorderD E Tsai, E A Stadtmauer, D J Canaday, et al.

Urology|May 9, 2003

Clinical characteristics of prostate cancer in African Americans, American whites, and Senegalese menS M Gueye, C M Zeigler-Johnson, T Friebel, et al.

International Journal of Radiation Oncology, Biology, Physics|December 29, 1999

Optimizing patient selection for dose escalation techniques using the prostate-specific antigen level, biopsy gleason score, and clinical T-stageA V D'Amico, R Whittington, S B Malkowicz, et al.

AJNR. American Journal of Neuroradiology|July 1, 1993

High-dose cytarabine neurotoxicity: MR findings during the acute phaseD J Vaughn, J G Jarvik, D Hackney, et al.

Cancer|January 28, 1998

Calculated prostate carcinoma volume: The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliterA V D'Amico, R Whittington, I Kaplan, et al.

The Journal of Urology|November 16, 2007

Toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: interim analysis of a multicenter phase 3 clinical studyM R Smith, S B Malkowicz, F Chu, et al.

International Journal of Radiation Oncology, Biology, Physics|October 6, 1997

Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTVA V D'Amico, R Whittington, I Kaplan, et al.

The Journal of Urology|November 20, 1997

Collagen injection therapy for post-radical retropubic prostatectomy incontinence: role of Valsalva leak point pressureR F Sánchez-Ortiz, G A Broderick, D C Chaikin, et al.

Urology|December 23, 2008

Does race affect postoperative outcomes in patients with low-risk prostate cancer who undergo radical prostatectomy?M J Resnick, D J Canter, T J Guzzo, et al.

Pageof 13